Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Stefani

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Cancer|March 29, 2024
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced non-small cell lung cancerEmanuele Vita, Federico Monaca, Domenico Milardi, et al.
Diagnostics (Basel, Switzerland)|April 12, 2025
The Role of ctDNA for Diagnosis and Histological Prediction in Early Stage Non-Small-Cell Lung Cancer: A Narrative ReviewCarolina Sassorossi, Jessica Evangelista, Alessio Stefani, et al.
Frontiers in Oncology|January 10, 2022
The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old FailuresMiriam Grazia Ferrara, Alessio Stefani, Sara Pilotto, et al.
Recenti Progressi in Medicina|July 1, 2023
[Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.]Gabriele Minuti, Alessio Stefani, Luca Trodella, et al.
Genes|August 28, 2025
Genomics in Lung Cancer: A Scoping Review of the Role of ctDNA in Non-Advanced Non-Small-Cell Lung Cancer in the Prediction of Prognosis After Multimodality Therapeutic ApproachesCarolina Sassorossi, Jessica Evangelista, Alessio Stefani, et al.
Frontiers in Oncology|November 17, 2022
Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancerAlessio Stefani, Geny Piro, Francesco Schietroma, et al.
Frontiers in Oncology|May 3, 2021
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future OpportunitiesMiriam Grazia Ferrara, Alessio Stefani, Michele Simbolo, et al.
Cancers|June 26, 2026
From Clinical Trials to Real-World Practice: Surgical Feasibility and Postoperative Outcomes After Neoadjuvant Chemoimmunotherapy for Locally Advanced NSCLC in a Single-Center ExperienceFilippo Lococo, Dania Nachira, Khrystyna Kuzmych, et al.
Recenti Progressi in Medicina|October 14, 2021
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]Gabriele Minuti, Alessio Stefani, Silvia Carpano, et al.
Clinical Lung Cancer|February 9, 2021
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase InhibitorsMiriam Grazia Ferrara, Maurizio Martini, Ettore D'Argento, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Cancer|March 29, 2024
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced non-small cell lung cancerEmanuele Vita, Federico Monaca, Domenico Milardi, et al.
Diagnostics (Basel, Switzerland)|April 12, 2025
The Role of ctDNA for Diagnosis and Histological Prediction in Early Stage Non-Small-Cell Lung Cancer: A Narrative ReviewCarolina Sassorossi, Jessica Evangelista, Alessio Stefani, et al.
Frontiers in Oncology|January 10, 2022
The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old FailuresMiriam Grazia Ferrara, Alessio Stefani, Sara Pilotto, et al.
Recenti Progressi in Medicina|July 1, 2023
[Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.]Gabriele Minuti, Alessio Stefani, Luca Trodella, et al.
Genes|August 28, 2025
Genomics in Lung Cancer: A Scoping Review of the Role of ctDNA in Non-Advanced Non-Small-Cell Lung Cancer in the Prediction of Prognosis After Multimodality Therapeutic ApproachesCarolina Sassorossi, Jessica Evangelista, Alessio Stefani, et al.
Frontiers in Oncology|November 17, 2022
Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancerAlessio Stefani, Geny Piro, Francesco Schietroma, et al.
Frontiers in Oncology|May 3, 2021
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future OpportunitiesMiriam Grazia Ferrara, Alessio Stefani, Michele Simbolo, et al.
Cancers|June 26, 2026
From Clinical Trials to Real-World Practice: Surgical Feasibility and Postoperative Outcomes After Neoadjuvant Chemoimmunotherapy for Locally Advanced NSCLC in a Single-Center ExperienceFilippo Lococo, Dania Nachira, Khrystyna Kuzmych, et al.
Recenti Progressi in Medicina|October 14, 2021
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]Gabriele Minuti, Alessio Stefani, Silvia Carpano, et al.
Clinical Lung Cancer|February 9, 2021
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase InhibitorsMiriam Grazia Ferrara, Maurizio Martini, Ettore D'Argento, et al.
Pageof 4